Related Experiment Video
Updated: May 25, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
Vanadium compounds affect growth and morphology of human rhabdomyosarcoma cell line
Wojciech Dąbroś1, Anna Adamczyk, Katarzyna Ciurkot
1Chair of Pathomorphology, Faculty of Medicine, Collegium Medicum Jagiellonian University, Cracow, Poland. mpdabros@cyf-kr.edu.pl
Abstract:
Rhabdomyosarcoma (RMS) cells were incubated with four vanadium compounds: cations BMOV and vanadyl sulphate, and anions ortho- and metavanadate. Growth inhibition of RMS cells in the culture was determined by two staining methods: with N-hexamethylpararosaniline (crystal violet = CV) or bromide 3-(4,5-dimethylthiazol-2)-2,5-diphenyltetrazolium (MTT). After 48 h incubation with 10-40 μM for NaVO3 or 20-40 μM for the other three vanadium salts, the results were statistically significantly lower (0.001 < p < 0.01) as compared to the controls (without vanadium in the medium). A vanadium concentration higher than 40 μM resulted in cell destruction or death in all cells. A comparison with our previously obtained results showed the greatest sensitivity of rat hepatoma H 35-19 cells in comparison to four human cancer cell lines (A549, DU145, HTB, RMS). Investigations of human cancer cells demonstrated that the highest resistance to orthovanadate was characteristic of RMS (c.40 μM) and HTB (c. 20 μM). Electron microscopic examination showed pleomorphic nuclei with visible amounts of heterochromatin and large nucleoli, characteristic of RMS cells. Cells at various stages of differentiation were observed.
Insights
Vanadium compounds inhibit rhabdomyosarcoma (RMS) cell growth. Concentrations above 40 μM caused cell death, with RMS cells showing resistance to orthovanadate.
Area of Science:
- Inorganic Chemistry
- Cell Biology
- Oncology
Background:
- Rhabdomyosarcoma (RMS) is a pediatric cancer.
- Vanadium compounds have shown cytotoxic effects on cancer cells.
- Understanding the impact of vanadium on RMS is crucial for potential therapeutic strategies.
Purpose of the Study:
- To investigate the effect of four vanadium compounds on the growth of rhabdomyosarcoma (RMS) cells.
- To determine the sensitivity and resistance of RMS cells to different vanadium salts.
- To compare the sensitivity of RMS cells to other human cancer cell lines.
Main Methods:
- Incubation of RMS cells with four vanadium compounds: BMOV, vanadyl sulphate, ortho-vanadate, and meta-vanadate.
- Quantification of cell growth inhibition using crystal violet (CV) and MTT assays.
- Statistical analysis of results compared to control groups.
- Electron microscopy for cellular morphology assessment.
Main Results:
- Statistically significant growth inhibition of RMS cells was observed after 48 h incubation with vanadium compounds (10-40 μM).
- Vanadium concentrations higher than 40 μM led to complete cell destruction.
- RMS cells exhibited resistance to orthovanadate (approx. 40 μM), showing higher resistance compared to other tested human cancer cell lines.
Conclusions:
- Vanadium compounds effectively inhibit RMS cell growth in vitro.
- RMS cells display a degree of resistance to orthovanadate, suggesting differential sensitivity among cancer types.
- Further research into vanadium-based therapies for RMS is warranted, considering dose-dependent cytotoxic effects and cell-specific resistance.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation
Mutagenicity and Carcinogenicity
Drugs that Destabilize Microtubules
